Arthropods transmit arboviruses via mosquito and tick bites to humans and other animals. The genus flavivirus, which causes diseases, sequelae, and thousands of deaths, mainly in developing and underdeveloped countries, is among the arboviruses of interest to public health. Given the importance of early and accurate diagnosis, this review analyzes the methods of direct detection of flaviviruses, such as reverse transcription loop-mediated isothermal amplification, microfluidics, localized surface plasmon resonance, and surface-enhanced Raman scattering, and presents the advantages, disadvantages, and detection limits identified in studies reported in the literature for each methodology. Among the different methods available, it is essential to balance four fundamental indicators to determine the ideal test: good sensitivity, high specificity, low false positive rate, and rapid results. Among the methods analyzed, reverse transcription loop-mediated isothermal amplification stands out, owing to result availability within a few minutes, with good sensitivity and specificity; in addition, it is the best-characterized methodology.
An accurate and rapid diagnosis of COVID-19 is an effective strategy for pandemic control, allowing disease screening and timely therapeutic intervention. We analyzed scientific reports about rapid tests for the diagnosis of COVID-19 to assess their reliability parameters. Medical Subject Headings terms or keywords related to point-of-care and rapid diagnostic testing for SARS-CoV-2 and COVID-19 were searched in data published from November 2020 to November 2021 in PubMed and Google Scholar databases. Notable differences were observed in sensitivity among direct tests that used different samples, and good accuracy was reported in a significant number of studies (>80%). Pediatric samples and samples with high Ct values (RT-PCR) had suboptimal sensitivity (range 45.4% to 66%). Further, a lack of sensitivity (60%). For serological detection of IgM or Antigen rapid diagnostic tests, no cross-reactivity was found with other coronaviruses. Therefore, although these tests are very important in facing the pandemic, they still need to be improved to test cross-reactivity against other pathogens, especially against other coronaviruses.
Dengue, Zika, yellow fever, chikungunya, and Mayaro arboviruses represent an increasing threat to public health because of the serious infections they cause annually in many countries. Serological diagnosis of these viruses is challenging, making the development of new diagnostic strategies imperative. In this study, we investigated the effectiveness of gold nanorods (GNRs) functionalized with specific anti-dengue and anti-orthoflavivirus antibodies in detecting viral particles. GNRs were created with a length-to-width ratio of up to 5.5, a size of 71.4 ± 6.5 nm, and a light absorption peak at 927 nm, and they were treated with 4 mM polyethyleneimine. These GNRs were attached to a small amount of monoclonal antibodies that target flaviviruses, and the viral particles were detected by measuring the localized surface plasmon resonance using an UV-Vis/NIR spectrometer. The tests found Orthoflavivirus dengue and Orthoflavivirus zikaense in diluted human serum and ground-up mosquitoes, with the lowest detectable amount being 100 PFU/mL. The GNRs described in this study can be used to enhance flavivirus diagnostic tests or to develop new, faster, and more accurate diagnostic techniques. Additionally, the functionalized GNRs presented here are promising for supporting virological surveillance studies in mosquitoes. Our findings highlight a fast and highly sensitive method for detecting Orthoflavivirus in both human and mosquito samples, with a detection limit as low as 100 PFU/mL.
Introduction: Colorectal cancer (CRC) is a significant public health concern, with increasing incidence and mortality rates in Brazil, reinforcing the need for prevention and early diagnosis strategies¹². Screening includes colonoscopy and serum markers such as carcinoembryonic antigen (CEA), which is widely used in patient follow-up but limited by low sensitivity and specificity³⁴. Therefore, identifying new biomarkers capable of improving patient stratification is essential.Objective: This study evaluated whether plasma cytokines and soluble factors differ among CRC patients classified according to serum CEA levels.Methods: Plasma samples from 21 patients were analyzed using Luminex and divided according to a cutoff value of 7.5 ng/mL⁵: CEA < 7.5 ng/mL (n = 15) and CEA > 7.5 ng/mL (n = 6). Comparisons were performed using the Mann–Whitney test.Results and Discussion: Age was similar between groups. As expected, CEA levels differed widely, confirming the proposed separation. Among soluble factors, CCL11 and CCL5 showed significantly higher levels in patients with lower CEA. For CCL11, mean values were 12.62 vs. 6.08 pg/mL (p = 0.025), while for CCL5 they were 442.5 vs. 218.8 pg/mL (p = 0.013). ROC curve analysis showed good discriminatory performance: CCL5 exhibited an AUC of 0.8286 (p = 0.015), with 85.71% sensitivity and 73.33% specificity; CCL11 showed an AUC of 0.8061 (p = 0.0252), with 85.71% sensitivity and 78.57% specificity. These findings suggest that both biomarkers have potential to distinguish patients according to CEA levels.In the context of CRC, CCL5 and CCL11 play complex roles within the tumor microenvironment. CCL5 is associated with greater tumor aggressiveness and the CCL5/CCR5 axis, which promotes tumor progression and immune evasion by activating pathways such as p65/STAT3-CSN5, stabilizing PD-L1, and reducing T-cell cytotoxicity⁶⁷⁸. CCL11 is often elevated in tumor tissue and plasma, indicating stromal remodeling and possible eosinophil recruitment, although tumors may inhibit such infiltration. In advanced stages, its increase may reflect a more permissive environment for tumor growth⁹¹⁰.Conclusion: CCL5 and CCL11 showed clear differences between groups defined by CEA levels, suggesting possible biological relevance in this stratification. With a larger sample size, these findings could be further validated and better understood.
Introdução: O câncer colorretal (CCR) é o segundo mais incidente em mortalidade no Brasil, com previsão de 45.630 novos casos anuais entre 2023 e 2025. O diagnóstico precoce contribui para um melhor prognóstico, porém o CCR é muitas vezes assintomático ou com sintomas inespecíficos nos estágios iniciais, reduzindo a taxa de detecção. Ademais, mesmo diagnosticado precocemente, o acompanhamento prognóstico do CCR é complexo e a identificação de novos biomarcadores poderia melhorar a precisão e o direcionamento do tratamento. Objetivo: Avaliar o perfil de citocinas plasmáticas em pacientes com CCR para identificar potenciais biomarcadores prognósticos da doença. Metodologia: Foram analisadas 23 amostras de plasma de pacientes com CCR usando a técnica Luminex, divididas conforme o estadiamento:9 amostras de pacientes com CCR localizado (estágios I e II) e 14 amostras de pacientes com CCR avançado (estágios III e IV). Foi utilizado o teste de Kolmogorov-Smirnov para avaliar a distribuição dos dados, e as comparações independentes entre os grupos foram realizadas pelo teste de Mann-Whitney. Resultados e Discussão: Foram identificados níveis elevados das citocinas IL-8 e IL-2Ra em pacientes nos estágios III-IV, em comparação com os pacientes nos estágios I-II. Dados da literatura sugerem que a IL-8 está superexpressa em CCR em relação aos tecidos normais, com níveis elevados correlacionados a pior prognóstico, especialmente em casos avançados. Em CCR, a IL-8 desempenha um papel importante como mediadora da interação entre células tumorais e estromais, promovendo inflamação, progressão tumoral, angiogênese e metástases. A IL-2Ra, por sua vez, é um marcador de linfócitos T ativados, frequentemente presente em células T regulatórias. Em CCR, níveis elevados de IL-2Ra estão associados a pior prognóstico, devido ao papel imunossupressor das T-regs no microambiente tumoral. Estudos mostraram que as células T-regs com alta expressão de IL-2Ra apresentam maior atividade imunossupressora, inibindo respostas imunes antígeno-específicas contra tumores e favorecendo a recorrência da doença. Conclusão: Nossos resultados sugerem que as citocinas IL-8 e IL-2Ra possuem potencial para auxiliar na análise prognóstica de pacientes com CCR. Análises futuras serão realizadas para avaliar a performance dessas citocinas na diferenciação entre doença localizada e avançada, visando identificar a aplicabilidade clínica desses biomarcadores.